Fig. 1From: Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIRStructures of Cabotegravir (AP1), Rilpivirine (AP2) and DPs (DP1, DP2, DP3, and DP4)Back to article page